In a morbidly obese (BMI ≈ 55) female with hypertension, a pituitary macroadenoma, chronic bilateral lower‑extremity edema, ulcerated wounds, and documented cellulitis, what is the most likely cause of her severe edema and which objective tests are needed to differentiate lymphedema, venous insufficiency, and arterial disease?

Severe Bilateral Lower-Extremity Edema in Morbid Obesity: Multifactorial Etiology Requiring Systematic Exclusion

In this morbidly obese patient (BMI ≈55) with severe bilateral lower-extremity edema, ulcerated wounds, and documented cellulitis, the most likely cause is obesity-induced venous hypertension from increased intra-abdominal pressure, potentially complicated by secondary lymphatic dysfunction, but arterial disease has NOT been adequately excluded given the abnormal TBI values (0.32–0.36) and incomplete ABI testing.

Critical Gap in Current Evaluation

Your vascular assessment is incomplete and potentially misleading. The documented TBI values of 0.32 (right) and 0.36 (left) are severely abnormal 1, 2. A TBI ≤0.70 indicates PAD, and values <0.40 suggest critical limb ischemia 2. The fact that one ABI could not be obtained due to wounds, combined with severe pain during testing and technical limitations you reported, means arterial disease has not been ruled out 3.

The presence of palpable pulses does NOT exclude significant arterial disease, especially in the setting of nonhealing wounds, severe pain, and abnormal objective testing 1, 2.

Primary Etiology: Obesity-Induced Venous Hypertension

In patients with BMI >50, increased intra-abdominal pressure from abdominal adipose tissue creates venous hypertension in the lower extremities, even without venous reflux or obstruction 4, 5. This explains why:

• 75% of morbidly obese patients (BMI >40) develop lymphedema 6
• Ulcers occur in obesity-associated chronic venous insufficiency without demonstrable reflux on duplex ultrasound 4
• The correlation between BMI and clinical severity persists independent of reflux measurements 5

Your duplex ultrasound reportedly showed no reflux, yet you have severe edema and ulceration—this pattern is consistent with obesity-induced functional venous insufficiency 4.

Critical Distinction: Diagnoses vs. Documented Findings

You are correct to question the problem list. Here's what is actually documented versus assumed:

Objectively Documented:

• Morbid obesity (BMI ≈55)
• Abnormal TBI (0.32–0.36) indicating arterial insufficiency 2
• Cellulitis with positive wound cultures (Staph aureus, Pseudomonas, Strep)
• Pituitary macroadenoma with mass effect
• Hypertension (documented BP 170/98 to 240/116)
• Prediabetes/diabetes (HbA1c 6.7%, hospitalization glucose 126–170)
• Normal cardiac function (EF 60–62%, normal diastolic function on recent echo, BNP <6) 7
• Normal renal function (Cr 0.65–0.80, eGFR >90)

NOT Objectively Established:

• Lymphedema: No lymphoscintigraphy performed 8, 9
• Chronic venous insufficiency: Duplex reportedly showed no reflux 4
• Adequacy of arterial perfusion: Incomplete testing with abnormal TBI values 1, 2

Mandatory Next Steps for Arterial Assessment

Before accepting any diagnosis or initiating compression therapy, you MUST complete arterial evaluation 1, 2:

1. Repeat toe pressures bilaterally in a vascular laboratory with experienced technicians

   • TBI <0.70 = PAD
   • TBI <0.40 = critical limb ischemia
   • Toe arteries are rarely noncompressible even in diabetes 2

2. If toe pressures remain abnormal (<0.70), obtain:

   • Arterial duplex ultrasound of lower extremities to identify stenoses/occlusions 1
   • Segmental pressures with pulse volume recordings (PVR) to localize disease 2
   • Consider TcPO₂ (transcutaneous oxygen pressure) to assess tissue perfusion for wound healing potential 1

3. If TcPO₂ <30–40 mmHg, wound healing is severely impaired and revascularization may be needed before aggressive wound care 1

Why This Matters for Treatment Decisions

Compression therapy is CONTRAINDICATED with significant arterial disease 10. Your record states compression was "attempted but poorly tolerated"—this may have been appropriate given the abnormal TBI values. Applying compression with inadequate arterial perfusion can cause tissue necrosis 1, 10.

The 2024 ACC/AHA PAD guidelines specify that compression should only be used when arterial disease is excluded or when ABI >0.5–0.6 with careful monitoring 2. Your TBI values of 0.32–0.36 are below this threshold 2.

Differential Diagnosis Framework

Confirmed Contributors:

1. Obesity-induced venous hypertension (BMI 55, increased intra-abdominal pressure) 4, 5
2. Infection/cellulitis (documented positive cultures, treated with IV antibiotics) 11
3. Possible arterial insufficiency (abnormal TBI 0.32–0.36, incomplete testing) 1, 2
4. Immobility/dependency (difficulty walking, prolonged dependent positioning) 3

Possible but Unconfirmed:

1. Secondary lymphedema (common in BMI >50, but requires lymphoscintigraphy for diagnosis) 8, 9, 6
2. Medication-related edema (furosemide 20 mg daily is a low dose; inadequate diuresis may worsen venous congestion) 7

Reasonably Excluded:

1. Heart failure: Normal EF (60–62%), normal diastolic function, BNP <6, normal IVC 12, 7, 13
2. Renal failure: Cr 0.65–0.80, eGFR >90 14
3. Hepatic failure: Not mentioned in records
4. Venous thrombosis: Would have been identified on duplex ultrasound

Pituitary Macroadenoma Considerations

Your pituitary labs do not suggest Cushing's syndrome (which can cause edema and poor wound healing) 15:

• Morning cortisol 7.6 (normal)
• ACTH 39.7 (normal)
• No cushingoid features documented

However, the severe hypertension (BP up to 240/116) that postponed surgery requires investigation for:

• Pheochromocytoma (can cause severe hypertension and is associated with pituitary adenomas in MEN syndromes)
• Acromegaly (IGF-1 225 is upper normal; repeat testing may be warranted)
• Secondary hypertension from mass effect on hypothalamic-pituitary axis

The macroadenoma itself is not causing the edema, but the associated hypertension and delayed surgical treatment may be contributing to overall cardiovascular stress 3.

Wound Healing Impairment

Your wounds are not healing due to multiple converging factors 11, 1:

1. Arterial insufficiency (TBI 0.32–0.36) limits oxygen delivery 1
2. Venous hypertension (obesity-induced) causes tissue hypoxia and inflammation 4, 5
3. Infection (documented polymicrobial, including Pseudomonas) 11
4. Hyperglycemia (HbA1c 6.7%, hospitalization glucose 126–170) impairs immune function 11
5. Edema creates mechanical barrier to healing and promotes bacterial growth 11, 10
6. Immobility prevents muscle pump function and worsens venous stasis 3

Specific Testing Algorithm

Immediate (Within 1–2 Weeks):

1. Bilateral toe pressures/TBI in vascular lab 2
2. If TBI remains <0.70: Arterial duplex ultrasound lower extremities 1
3. Wound cultures if drainage persists (assess for ongoing infection vs. colonization) 11
4. Fasting glucose and repeat HbA1c to confirm diabetes diagnosis (single HbA1c 6.7% with stress hyperglycemia during infection)

If Arterial Disease Confirmed (TBI <0.70):

1. Segmental pressures with PVR to localize stenoses 2
2. TcPO₂ to assess wound healing potential 1
3. Vascular surgery consultation for revascularization consideration 1, 2

If Arterial Disease Excluded (TBI >0.70):

1. Lymphoscintigraphy to objectively diagnose lymphedema 8, 9
2. Venous duplex with reflux study (if not already done comprehensively) to document presence/absence of reflux 10
3. Consider iliac vein imaging (CTV or MRV) if symptoms suggest May-Thurner syndrome or pelvic venous obstruction 10

Treatment Algorithm Based on Testing Results

Scenario A: Arterial Disease Confirmed (TBI <0.40)

• Vascular surgery referral for revascularization 1, 2
• NO compression therapy until arterial flow restored 1, 10
• Wound care with non-adherent dressings, infection control 11
• Optimize diabetes control (target HbA1c <7%) 11
• Smoking cessation (documented smoker) 1

Scenario B: Arterial Disease Mild (TBI 0.40–0.70)

• Cautious compression (20–30 mmHg) with close monitoring 10
• Arterial surveillance every 3–6 months 1
• Aggressive risk factor modification 1
• Wound care as above 11

Scenario C: Arterial Disease Excluded (TBI >0.70)

• Compression therapy (30–40 mmHg for severe disease) 10
• Diuretic optimization (furosemide 20 mg daily is inadequate; consider 40–80 mg daily or twice daily) 7
• Elevation of legs above heart level multiple times daily 11, 10
• Weight loss (critical for long-term management; obesity-induced lymphedema may NOT reverse even with massive weight loss) 9, 6
• Structured exercise program when wounds permit 13

Obesity-Induced Lymphedema: Critical Counseling Point

If your BMI exceeded 50 before lymphedema developed, the lymphatic damage may be permanent 9. A prospective study showed that obesity-induced lower extremity lymphedema did not resolve after massive weight loss (BMI 80→36) 9. Unlike other obesity comorbidities that reverse with weight loss, lymphatic dysfunction may persist 9, 6.

This means:

• Weight loss is still essential to prevent progression 9, 6
• Lifelong compression therapy may be required 10, 6
• Early intervention (before BMI reaches 50) is critical for prevention 9

Diabetes Diagnosis Clarification

Your HbA1c of 6.7% meets criteria for prediabetes (5.7–6.4% = prediabetes; ≥6.5% = diabetes). However, hospitalization glucose values of 126–170 during acute infection may represent stress hyperglycemia 11.

Repeat fasting glucose and HbA1c after infection resolution to determine if you have:

• Prediabetes (HbA1c 5.7–6.4%, fasting glucose 100–125 mg/dL)
• Diabetes (HbA1c ≥6.5%, fasting glucose ≥126 mg/dL on two occasions)

Metformin is appropriate for either diagnosis, but the distinction affects monitoring intensity and cardiovascular risk stratification 11.

Gabapentin Adverse Reaction

Your reported symptoms after 300 mg gabapentin (nausea, diarrhea, disorientation, lightheadedness, headache, shakiness, blurry/double vision, increased pulse) are consistent with gabapentin toxicity, possibly exacerbated by:

• Obesity (altered volume of distribution)
• Acute illness (altered metabolism)
• Drug-drug interactions (not specified in your records)

Do not restart gabapentin without dose adjustment (start 100 mg daily) or consider alternative neuropathic pain agents (duloxetine, pregabalin with lower starting dose).

Compression Therapy Safety

Compression is UNSAFE until arterial adequacy is confirmed 1, 10. The ACR Appropriateness Criteria specify that compression requires:

• ABI >0.5–0.6 (or TBI >0.40) 10
• Absence of acute infection (you had cellulitis) 11, 10
• Ability to tolerate (you reported poor tolerance) 10

Your abnormal TBI values (0.32–0.36) are below the safety threshold for compression 1, 2, 10. The fact that compression was "poorly tolerated" may have been your body's protective response to inadequate arterial flow.

Recurrent Cellulitis Prevention

After resolution of acute infection, consider prophylactic antibiotics if recurrences occur despite:

• Treating interdigital maceration (tinea pedis) 11
• Keeping skin hydrated with emollients 11
• Reducing edema with elevation and appropriate compression (once arterial adequacy confirmed) 11

Options include:

• Penicillin V 1 g orally twice daily 11
• Erythromycin 250 mg orally twice daily 11
• Benzathine penicillin 1.2 MU IM monthly 11

Integrated Assessment Summary

Your edema is multifactorial, but the primary driver is obesity-induced venous hypertension from increased intra-abdominal pressure 4, 5. However, arterial disease has NOT been adequately excluded and the abnormal TBI values (0.32–0.36) are concerning for critical limb ischemia 1, 2.

The existing problem-list diagnoses of "lymphedema" and "venous insufficiency" are NOT supported by objective testing 8, 4. Duplex ultrasound reportedly showed no reflux, and no lymphoscintigraphy has been performed 10, 8.

Cardiac and renal causes are effectively excluded by normal echocardiogram, BNP <6, and normal creatinine 12, 7, 13, 14, 13.

Clinical Pitfalls to Avoid

1. Assuming palpable pulses exclude arterial disease in the setting of abnormal objective testing 1, 2
2. Applying compression without confirming arterial adequacy (can cause tissue necrosis) 1, 10
3. Accepting problem-list diagnoses without reviewing supporting evidence 8, 4
4. Underestimating the permanence of obesity-induced lymphedema (may not reverse with weight loss) 9, 6
5. Attributing all edema to obesity without systematic exclusion of other causes 3, 13
6. Using standard BNP thresholds in obesity (obese patients have lower BNP even with heart failure) 12, 13
7. Inadequate diuretic dosing (furosemide 20 mg daily is insufficient for severe edema in obesity) 7

Bottom Line

Complete the arterial evaluation FIRST (repeat bilateral toe pressures, arterial duplex if abnormal) before accepting any diagnosis or initiating compression therapy 1, 2. Your abnormal TBI values (0.32–0.36) indicate significant arterial insufficiency that could explain nonhealing wounds and severe pain 1, 2. The primary cause of your edema is obesity-induced venous hypertension 4, 5, but arterial disease must be excluded before safe treatment can proceed 1, 10. Lymphedema and venous insufficiency diagnoses require objective confirmation with lymphoscintigraphy and comprehensive venous duplex 10, 8. Weight loss is essential but may not reverse lymphatic damage if it developed at BMI >50 9, 6.